本页面由Tiger Trade Technology Pte. Ltd.提供服务

TransCode Therapeutics Inc.

8.70
+0.16001.87%
盘后8.700.00000.00%16:10 EDT
成交量:6,556.00
成交额:5.79万
市值:797.76万
市盈率:-0.04
高:9.32
开:8.87
低:8.52
收:8.54
52周最高:22.03
52周最低:6.08
股本:91.70万
流通股本:83.24万
量比:0.86
换手率:0.79%
股息:- -
股息率:- -
每股收益(TTM):-236.5200
每股收益(LYR):-1,317.4218
净资产收益率:-1763.01%
总资产收益率:-232.54%
市净率:5.59
市盈率(LYR):-0.01

数据加载中...

2024/07/27

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/24

重要事件披露

Form 8-K - Current report
2024/06/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/05

重要事件披露

Form 8-K - Current report
2024/04/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/18

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/17

SEC问询函

Form CORRESP - Correspondence